Is Insmed (INSM) The Best Healthcare Stock to Buy Now?

Druckenmiller’s Stake: $188,717,000

Insmed (NASDAQ:INSM) makes treatments for superior lung diseases caused by chronic inflammation oregon infection. Its halfway products are Brinsupri (brensocatib) and Arikayce.

In 2025, Brinsupri generated astir $144.6 cardinal successful Q4 sales, bringing full-year gross to astir $600+ million, reflecting precise beardown aboriginal motorboat growth. This represents astir 67% year-over-year growth. For 2026, Insmed expects Brinsupri to deed astir $1 cardinal successful yearly sales, driven by broader diligent adoption.

Arikayce successful 2025 generated astir $433.8 cardinal successful full-year sales, up 19% twelvemonth implicit year, and the institution guided 2026 income of $450–$470 million.

Insmed’s (NASDAQ:INSM) pipeline is besides strong. One cardinal campaigner is TPIP (treprostinil inhalation powder), a attraction being developed for PAH (pulmonary arterial hypertension) and PH-ILD (pulmonary hypertension associated with interstitial lung disease). Some estimates suggest the merchandise tin perchance make implicit $4 cardinal successful highest yearly sales.

Artisan Small Cap Fund stated the pursuing regarding Insmed Incorporated (NASDAQ:INSM) successful its fourth 4th 2025 capitalist letter:

“Our apical contributors successful Q4 were MACOM Technology Solutions, Insmed Incorporated (NASDAQ:INSM) and Vita Coco. Insmed is simply a biotechnology institution focused connected pulmonary diseases. We exited our presumption during the 4th owed to marketplace headdress considerations, though the banal remained a apical performer. Its spot was driven by the palmy motorboat of Brinsupri™ (brensocatib), the archetypal approved therapy for non-cystic fibrosis bronchiectasis, which generated $28 cardinal successful archetypal income from astir 2,500 patients and 1,700 prescribers, on with a robust pipeline of further imaginable therapies (Click Here to Read the Letter successful Detail).”

While we admit the imaginable of INSM arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey connected Google News.